Akanksha Singh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Akanksha Singh has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Namita Agrawal
Department of Zoology, University of Delhi, North Campus, Chhatra Marg, Delhi-110007, India
5 shared publications Prasanna Shah
Acropolis Institute of Technology and Research
4 shared publicationsAkanksha Raj
University of Delhi
3 shared publicationsNamita Agrawal
University of Delhi
3 shared publications- Alex Livingston Raja Antony Raj
Hindusthan College of Engineering and Technology, India
1 shared publication - Anjana S. Desai
Department of Applied Science, Symbiosis Institute of Technology, Symbiosis International (Deemed) University, Pune 412115, India
1 shared publication
Latest Publications
- 19 September 2022
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 37 (8) , 2783-2792
Progressive transcriptional changes in metabolic genes and altered fatbody homeostasis in Drosophila model of Huntington’s disease
Huntington’s disease (HD) is an autosomal-dominant neurodegenerative disorder marked by progressive neuronal atrophy, particularly in striatum and cerebral cortex. Although predominant manifestations of the disease include loss in the triad of motor, cognitive and behavioral capabilities, metabolic dysfunction in patients and HD models are being increasingly recognized. Patients display progressive body weight loss, which aggravates the disease and leads to cachexia in the terminal stages. Using the Drosophila model of HD, we have earlier reported that diseased flies exhibit an atypical pattern of lipid gain and loss with progression along with exhibiting extensive mitochondrial dysfunction, impaired calcium homeostasis and heightened apoptosis in the fatbody. Here, we first monitored the structural changes that abdominal fatbody undergoes with disease progression. Further, we checked the transcriptional changes of key metabolic genes in whole fly as well as genes regulating mitochondrial function, apoptosis, autophagy and calcium homeostasis in the abdominal fatbody. We found extensive alterations in whole-body and fatbody-specific transcriptional profile of the diseased flies, which was in consort with their stage-specific physiological state. Additionally, we also assessed lysosome-mediated autophagy in the fatbody of diseased flies in order to ascertain the mechanisms contributing to fatbody atrophy at the terminal stage. Interestingly, we found elevated autophagy in fatbody of flies throughout disease progression. This study provides new insights into the effect on peripheral metabolism due to degeneration of neurons in the neurodegenerative disease, thereby discerns novel mechanisms leading to cachexia in diseased flies and advocates for the need of managing metabolic dysfunctions in HD.
- 19 September 2022
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 37 (8) , 2783-2792
Progressive transcriptional changes in metabolic genes and altered fatbody homeostasis in Drosophila model of Huntington’s disease
Huntington’s disease (HD) is an autosomal-dominant neurodegenerative disorder marked by progressive neuronal atrophy, particularly in striatum and cerebral cortex. Although predominant manifestations of the disease include loss in the triad of motor, cognitive and behavioral capabilities, metabolic dysfunction in patients and HD models are being increasingly recognized. Patients display progressive body weight loss, which aggravates the disease and leads to cachexia in the terminal stages. Using the Drosophila model of HD, we have earlier reported that diseased flies exhibit an atypical pattern of lipid gain and loss with progression along with exhibiting extensive mitochondrial dysfunction, impaired calcium homeostasis and heightened apoptosis in the fatbody. Here, we first monitored the structural changes that abdominal fatbody undergoes with disease progression. Further, we checked the transcriptional changes of key metabolic genes in whole fly as well as genes regulating mitochondrial function, apoptosis, autophagy and calcium homeostasis in the abdominal fatbody. We found extensive alterations in whole-body and fatbody-specific transcriptional profile of the diseased flies, which was in consort with their stage-specific physiological state. Additionally, we also assessed lysosome-mediated autophagy in the fatbody of diseased flies in order to ascertain the mechanisms contributing to fatbody atrophy at the terminal stage. Interestingly, we found elevated autophagy in fatbody of flies throughout disease progression. This study provides new insights into the effect on peripheral metabolism due to degeneration of neurons in the neurodegenerative disease, thereby discerns novel mechanisms leading to cachexia in diseased flies and advocates for the need of managing metabolic dysfunctions in HD.
- Open Access
- 10 May 2022
- Published by MDPI AG in Journal of Functional Biomaterials
- Vol. 13 (2) , 54
An In Vitro and In Vivo Study of the Efficacy and Toxicity of Plant-Extract-Derived Silver Nanoparticles
Silver nanoparticles (AgNPs) display unique plasmonic and antimicrobial properties, enabling them to be helpful in various industrial and consumer products. However, previous studies showed that the commercially acquired silver nanoparticles exhibit toxicity even in small doses. Hence, it was imperative to determine suitable synthesis techniques that are the most economical and least toxic to the environment and biological entities. Silver nanoparticles were synthesized using plant extracts and their physico-chemical properties were studied. A time-dependent in vitro study using HEK-293 cells and a dose-dependent in vivo study using a Drosophila model helped us to determine the correct synthesis routes. Through biological analyses, we found that silver nanoparticles’ cytotoxicity and wound-healing capacity depended on size, shape, and colloidal stability. Interestingly, we observed that out of all the synthesized AgNPs, the ones derived from the turmeric extract displayed excellent wound-healing capacity in the in vitro study. Furthermore, the same NPs exhibited the least toxic effects in an in vivo study of ingestion of these NPs enriched food in Drosophila, which showed no climbing disability in flies, even at a very high dose (250 mg/L) for 10 days. We propose that stabilizing agents played a superior role in establishing the bio-interaction of nanoparticles. Our study reported here verified that turmeric-extract-derived AgNPs displayed biocompatibility while exhibiting the least cytotoxicity.
- 10 May 2022
- Published by MDPI AG in Journal of Functional Biomaterials
- Vol. 13 (2) , 54
Open AccessAn In Vitro and In Vivo Study of the Efficacy and Toxicity of Plant-Extract-Derived Silver Nanoparticles
Silver nanoparticles (AgNPs) display unique plasmonic and antimicrobial properties, enabling them to be helpful in various industrial and consumer products. However, previous studies showed that the commercially acquired silver nanoparticles exhibit toxicity even in small doses. Hence, it was imperative to determine suitable synthesis techniques that are the most economical and least toxic to the environment and biological entities. Silver nanoparticles were synthesized using plant extracts and their physico-chemical properties were studied. A time-dependent in vitro study using HEK-293 cells and a dose-dependent in vivo study using a Drosophila model helped us to determine the correct synthesis routes. Through biological analyses, we found that silver nanoparticles’ cytotoxicity and wound-healing capacity depended on size, shape, and colloidal stability. Interestingly, we observed that out of all the synthesized AgNPs, the ones derived from the turmeric extract displayed excellent wound-healing capacity in the in vitro study. Furthermore, the same NPs exhibited the least toxic effects in an in vivo study of ingestion of these NPs enriched food in Drosophila, which showed no climbing disability in flies, even at a very high dose (250 mg/L) for 10 days. We propose that stabilizing agents played a superior role in establishing the bio-interaction of nanoparticles. Our study reported here verified that turmeric-extract-derived AgNPs displayed biocompatibility while exhibiting the least cytotoxicity.
- Open Access
- 9 February 2022
- Published by Elsevier in SSRN Electronic Journal
Progressive Transcriptional Changes of Key Metabolic Genes and Altered Fatbody Homeostasis in Drosophila Model of Huntington's Disease
Progressive body weight loss independent of caloric intake presents a major challenge for management of Huntington’s disease. Using Drosophila model of HD, we earlier reported that diseased flies exhibit an atypical pattern of lipid gain and loss, and their fatbody exhibits extensive mitochondrial dysfunction, impaired calcium homeostasis and heightened apoptosis with progression. Here, we aimed to further decipher key cellular and molecular processes in fatbody of diseased flies which contribute to maintain its integrity. Using the transgenic Drosophila HD model, we studied the morphology of fatbody with progression. Further, we monitored transcriptional changes of key metabolic genes in whole fly along with genes regulating mitochondrial function, apoptosis, autophagy and calcium homeostasis in the abdominal fatbody. Additionally, we assessed lysosome-mediated autophagy in the fatbody of diseased flies with progression. We found that the fatbody of HD flies undergoes a dynamic change in morphology, which corresponds to alteration in lipid content. Extensive alterations in whole-body and fatbody-specific transcriptional profile of the diseased flies, which was in consort with their stage-specific physiological manifestations were documented. Interestingly, we found the fatbody of diseased flies show enhanced autophagy from early stage onwards. This study highlights novel transcriptional changes in whole body and fatbody of HD flies and implies a role of induced autophagy in a peripheral tissue i.e., fatbody, upon neuronal expression of mutant huntingtin. Therefore, we provide insights into novel mechanisms leading to cachexia in flies and reiterate the need for managing metabolic dysfunctions in HD.
- 9 February 2022
- Published by Elsevier in SSRN Electronic Journal
Open AccessProgressive Transcriptional Changes of Key Metabolic Genes and Altered Fatbody Homeostasis in Drosophila Model of Huntington's Disease
Progressive body weight loss independent of caloric intake presents a major challenge for management of Huntington’s disease. Using Drosophila model of HD, we earlier reported that diseased flies exhibit an atypical pattern of lipid gain and loss, and their fatbody exhibits extensive mitochondrial dysfunction, impaired calcium homeostasis and heightened apoptosis with progression. Here, we aimed to further decipher key cellular and molecular processes in fatbody of diseased flies which contribute to maintain its integrity. Using the transgenic Drosophila HD model, we studied the morphology of fatbody with progression. Further, we monitored transcriptional changes of key metabolic genes in whole fly along with genes regulating mitochondrial function, apoptosis, autophagy and calcium homeostasis in the abdominal fatbody. Additionally, we assessed lysosome-mediated autophagy in the fatbody of diseased flies with progression. We found that the fatbody of HD flies undergoes a dynamic change in morphology, which corresponds to alteration in lipid content. Extensive alterations in whole-body and fatbody-specific transcriptional profile of the diseased flies, which was in consort with their stage-specific physiological manifestations were documented. Interestingly, we found the fatbody of diseased flies show enhanced autophagy from early stage onwards. This study highlights novel transcriptional changes in whole body and fatbody of HD flies and implies a role of induced autophagy in a peripheral tissue i.e., fatbody, upon neuronal expression of mutant huntingtin. Therefore, we provide insights into novel mechanisms leading to cachexia in flies and reiterate the need for managing metabolic dysfunctions in HD.
- 27 October 2021
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 37 (6) , 1757-1771
Metabolism in Huntington’s disease: a major contributor to pathology
Huntington’s disease (HD) is a progressively debilitating neurodegenerative disease exhibiting autosomal-dominant inheritance. It is caused by an unstable expansion in the CAG repeat tract of HD gene, which transforms the disease-specific Huntingtin protein (HTT) to a mutant form (mHTT). The profound neuronal death in cortico-striatal circuits led to its identification and characterisation as a neurodegenerative disease. However, equally disturbing are the concomitant whole-body manifestations affecting nearly every organ of the diseased individuals, at varying extents. Altered central and peripheral metabolism of energy, proteins, nucleic acids, lipids and carbohydrates encompass the gross pathology of the disease. Intense fluctuation of body weight, glucose homeostasis and organ-specific subcellular abnormalities are being increasingly recognised in HD. Many of these metabolic abnormalities exist years before the neuropathological manifestations such as chorea, cognitive decline and behavioural abnormalities develop, and prove to be reliable predictors of the disease progression. In this review, we provide a consolidated overview of the central and peripheral metabolic abnormalities associated with HD, as evidenced from clinical and experimental studies. Additionally, we have discussed the potential of metabolic biomolecules to translate into efficient biomarkers for the disease onset as well as progression. Finally, we provide a brief outlook on the efficacy of existing therapies targeting metabolic remediation. While it is clear that components of altered metabolic pathways can mark many aspects of the disease, it is only conceivable that combinatorial therapies aiming for neuronal protection in consort with metabolic upliftment will prove to be more efficient than the existing symptomatic treatment options.
- 27 October 2021
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 37 (6) , 1757-1771
Metabolism in Huntington’s disease: a major contributor to pathology
Huntington’s disease (HD) is a progressively debilitating neurodegenerative disease exhibiting autosomal-dominant inheritance. It is caused by an unstable expansion in the CAG repeat tract of HD gene, which transforms the disease-specific Huntingtin protein (HTT) to a mutant form (mHTT). The profound neuronal death in cortico-striatal circuits led to its identification and characterisation as a neurodegenerative disease. However, equally disturbing are the concomitant whole-body manifestations affecting nearly every organ of the diseased individuals, at varying extents. Altered central and peripheral metabolism of energy, proteins, nucleic acids, lipids and carbohydrates encompass the gross pathology of the disease. Intense fluctuation of body weight, glucose homeostasis and organ-specific subcellular abnormalities are being increasingly recognised in HD. Many of these metabolic abnormalities exist years before the neuropathological manifestations such as chorea, cognitive decline and behavioural abnormalities develop, and prove to be reliable predictors of the disease progression. In this review, we provide a consolidated overview of the central and peripheral metabolic abnormalities associated with HD, as evidenced from clinical and experimental studies. Additionally, we have discussed the potential of metabolic biomolecules to translate into efficient biomarkers for the disease onset as well as progression. Finally, we provide a brief outlook on the efficacy of existing therapies targeting metabolic remediation. While it is clear that components of altered metabolic pathways can mark many aspects of the disease, it is only conceivable that combinatorial therapies aiming for neuronal protection in consort with metabolic upliftment will prove to be more efficient than the existing symptomatic treatment options.
- 25 August 2020
- Published by Springer Nature
- p. 107-122
Safe Dose of Nanoparticles: A Boon for Consumer Goods and Biomedical Application
- 25 August 2020
- Published by Springer Nature
- p. 107-122
Safe Dose of Nanoparticles: A Boon for Consumer Goods and Biomedical Application
- 25 August 2020
- Published by Springer Nature
- p. 1-27
Synthesis and Characterization of Nanoparticles Used in Consumer Products
- 25 August 2020
- Published by Springer Nature
- p. 1-27
Synthesis and Characterization of Nanoparticles Used in Consumer Products
- 17 August 2020
- Published by SAGE Publications in Toxicology and Industrial Health
- Vol. 36 (10) , 769-778
Discriminatory alteration of carbohydrate homeostasis by gold nanoparticles ingestion in Drosophila
With the extensive usage of gold nanoparticles (AuNPs) in various industrial sectors and biomedical applications, evaluation of their possible effects on human health becomes imperative. Therefore, the present study was aimed toward assessing the dose-dependent impact of AuNPs ingestion on metabolic homeostasis using Drosophila melanogaster as a model system. We found that larval ingestion of higher dose of AuNPs significantly reduced body weight. Further analysis of the crucial energy reservoir showed selective alteration in carbohydrate levels without any change in the lipid and protein levels. Transcriptional downregulation of glycogen synthase further supported impaired glycogen metabolism in flies supplemented with higher dose of AuNPs. Additionally, ingestion of higher dose of AuNPs in larvae results in significantly increased levels of reactive oxygen species (ROS) in the peripheral tissues, suggestive of stress condition. Our findings clearly imply that supplementing higher doses of AuNPs at an early developmental stage can potentially cause weight loss, impair glycogen metabolism, and elevate ROS production. Therefore, determination of a biologically effective dose is critical for the safety of mankind and vulnerable populations at the workplace.
- 17 August 2020
- Published by SAGE Publications in Toxicology and Industrial Health
- Vol. 36 (10) , 769-778
Discriminatory alteration of carbohydrate homeostasis by gold nanoparticles ingestion in Drosophila
With the extensive usage of gold nanoparticles (AuNPs) in various industrial sectors and biomedical applications, evaluation of their possible effects on human health becomes imperative. Therefore, the present study was aimed toward assessing the dose-dependent impact of AuNPs ingestion on metabolic homeostasis using Drosophila melanogaster as a model system. We found that larval ingestion of higher dose of AuNPs significantly reduced body weight. Further analysis of the crucial energy reservoir showed selective alteration in carbohydrate levels without any change in the lipid and protein levels. Transcriptional downregulation of glycogen synthase further supported impaired glycogen metabolism in flies supplemented with higher dose of AuNPs. Additionally, ingestion of higher dose of AuNPs in larvae results in significantly increased levels of reactive oxygen species (ROS) in the peripheral tissues, suggestive of stress condition. Our findings clearly imply that supplementing higher doses of AuNPs at an early developmental stage can potentially cause weight loss, impair glycogen metabolism, and elevate ROS production. Therefore, determination of a biologically effective dose is critical for the safety of mankind and vulnerable populations at the workplace.